The CpG island methylator phenotype in colorectal cancer : studies on risk and prognosis
Background Colorectal cancer (CRC) is the second most common malignancy in developed countries. The mortality is high, with nearly half of patients dying from the disease. The primary treatment of CRC is surgery, and decisions about additional treatment with chemotherapy are based mainly on tumor st...
Main Author: | Dahlin, Anna |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Umeå universitet, Patologi
2011
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-41270 http://nbn-resolving.de/urn:isbn:978-91-7459-177-4 |
Similar Items
-
Colorectal Cancer Screening: A Comprehensive Review to Recent Non-invasive Methods
by: Leila Hamzehzadeh, et al.
Published: (2017-07-01) -
Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer
by: Jiang Liu, et al.
Published: (2019-11-01) -
Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP)
by: Shih-Ching Chang, et al.
Published: (2020-11-01) -
Fusobacterium nucleatum infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage
by: Yoshiki Okita, et al.
Published: (2020-09-01) -
Colorectal Cancer "Methylator Phenotype": Fact or Artifact?
by: Charles Anacleto, et al.
Published: (2005-04-01)